H

Hanall Biopharma Co Ltd
KRX:009420

Watchlist Manager
Hanall Biopharma Co Ltd
KRX:009420
Watchlist
Price: 42 200 KRW -0.71% Market Closed
Market Cap: 2.2T KRW

Intrinsic Value

The intrinsic value of one Hanall Biopharma Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 42 200 KRW, Hanall Biopharma Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Hanall Biopharma Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hanall Biopharma Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Hanall Biopharma Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Hanall Biopharma Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Hanall Biopharma Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hanall Biopharma Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hanall Biopharma Co Ltd.

Explain Valuation
Compare Hanall Biopharma Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hanall Biopharma Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hanall Biopharma Co Ltd

Current Assets 67.7B
Cash & Short-Term Investments 8.5B
Receivables 18.3B
Other Current Assets 40.8B
Non-Current Assets 123B
Long-Term Investments 32.4B
PP&E 17.8B
Intangibles 58.8B
Other Non-Current Assets 14.1B
Current Liabilities 27.1B
Accounts Payable 5.1B
Accrued Liabilities 2.6B
Other Current Liabilities 19.3B
Non-Current Liabilities 7.5B
Long-Term Debt 674.1m
Other Non-Current Liabilities 6.8B
Efficiency

Free Cash Flow Analysis
Hanall Biopharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hanall Biopharma Co Ltd

Revenue
150.1B KRW
Cost of Revenue
-70.1B KRW
Gross Profit
80B KRW
Operating Expenses
-76B KRW
Operating Income
3.9B KRW
Other Expenses
-1.7B KRW
Net Income
2.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hanall Biopharma Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
ROE is Increasing
hidden
Profitability
Score

Hanall Biopharma Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hanall Biopharma Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Hanall Biopharma Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hanall Biopharma Co Ltd

Wall Street analysts forecast Hanall Biopharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hanall Biopharma Co Ltd is 44 734.29 KRW with a low forecast of 40 400 KRW and a high forecast of 52 500 KRW.

Lowest
Price Target
40 400 KRW
4% Downside
Average
Price Target
44 734.29 KRW
6% Upside
Highest
Price Target
52 500 KRW
24% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hanall Biopharma Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hanall Biopharma Co Ltd stock?

The intrinsic value of one Hanall Biopharma Co Ltd stock under the Base Case scenario is hidden KRW.

Is Hanall Biopharma Co Ltd stock undervalued or overvalued?

Compared to the current market price of 42 200 KRW, Hanall Biopharma Co Ltd is hidden .

Back to Top